Sang Y. Cho
Daejeon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
The Solute Carrier Superfamily as Therapeutic Targets in Pancreatic Ductal Adenocarcinoma.
Journal: Genes
Published: March 14, 2025
The Solute Carrier (SLC) Transporter Superfamily as Therapeutic Targets for the Treatment of Ovarian Serous Cystadenocarcinoma.
Journal: Reproductive sciences (Thousand Oaks, Calif.)
Published: September 19, 2024
The Solute Carrier (SLC) Transporter Superfamily as Therapeutic Targets for the Treatment of Head and Neck Squamous Cell Carcinoma.
Journal: Cancers
Published: August 27, 2024
ATG9B Is a Poor Prognostic Marker Associated With Immune Evasion in Colon Adenocarcinoma.
Journal: Anticancer research
Published: February 06, 2023
Targeting YAP-p62 signaling axis suppresses the EGFR-TKI-resistant lung adenocarcinoma.
Journal: Cancer medicine
Published: September 04, 2020
TEAD2 as a novel prognostic factor for hepatocellular carcinoma.
Journal: Oncology reports
Published: August 21, 2019
Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma.
Journal: BMC cancer
Published: July 30, 2019
Clinical significance of atypical protein kinase C (PKCι and PKCζ) and its relationship with yes-associated protein in lung adenocarcinoma.
Journal: BMC cancer
Published: January 20, 2019
Clinical Significance of the Thioredoxin System and Thioredoxin-Domain-Containing Protein Family in Hepatocellular Carcinoma.
Journal: Digestive diseases and sciences
Published: July 05, 2018
Profiling cytochrome P450 family 4 gene expression in human hepatocellular carcinoma.
Journal: Molecular medicine reports
Published: May 17, 2018
Last Updated: 09/26/2026